Erica J. Brenner

2.6k total citations · 1 hit paper
32 papers, 905 citations indexed

About

Erica J. Brenner is a scholar working on Genetics, Infectious Diseases and Epidemiology. According to data from OpenAlex, Erica J. Brenner has authored 32 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 12 papers in Infectious Diseases and 9 papers in Epidemiology. Recurrent topics in Erica J. Brenner's work include Inflammatory Bowel Disease (20 papers), COVID-19 Clinical Research Studies (10 papers) and Microscopic Colitis (8 papers). Erica J. Brenner is often cited by papers focused on Inflammatory Bowel Disease (20 papers), COVID-19 Clinical Research Studies (10 papers) and Microscopic Colitis (8 papers). Erica J. Brenner collaborates with scholars based in United States, Austria and Canada. Erica J. Brenner's co-authors include Michael D. Kappelman, Jean‐Frédéric Colombel, Ryan C. Ungaro, Walter Reinisch, Gilaad G. Kaplan, Jean‐François Rahier, Flávio Steinwurz, Michele Kissous-Hunt, Richard B. Gearry and James D. Lewis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

Erica J. Brenner

27 papers receiving 894 citations

Hit Papers

Corticosteroids, But Not TNF Antagonists, Are Associated ... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erica J. Brenner United States 12 639 290 260 177 112 32 905
Michele Kissous-Hunt United States 6 528 0.8× 229 0.8× 191 0.7× 149 0.8× 81 0.7× 10 773
Mark Yates United Kingdom 14 248 0.4× 147 0.5× 54 0.2× 125 0.7× 105 0.9× 38 819
Joyce Popoola United Kingdom 13 272 0.4× 118 0.4× 49 0.2× 124 0.7× 56 0.5× 28 806
Roni Baruch Israel 12 493 0.8× 161 0.6× 32 0.1× 50 0.3× 161 1.4× 27 924
Danny Wong United States 10 174 0.3× 113 0.4× 88 0.3× 52 0.3× 177 1.6× 20 465
Gili Focht Israel 14 183 0.3× 87 0.3× 464 1.8× 30 0.2× 316 2.8× 53 694
Rebecca E. Sadun United States 15 329 0.5× 121 0.4× 31 0.1× 120 0.7× 52 0.5× 51 881
Vinay Nair United States 14 216 0.3× 153 0.5× 21 0.1× 92 0.5× 133 1.2× 35 843
Maria Therese Ahlén Norway 11 390 0.6× 38 0.1× 132 0.5× 150 0.8× 43 0.4× 33 1.4k
Anders Husby Denmark 12 273 0.4× 130 0.4× 26 0.1× 36 0.2× 48 0.4× 18 609

Countries citing papers authored by Erica J. Brenner

Since Specialization
Citations

This map shows the geographic impact of Erica J. Brenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erica J. Brenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erica J. Brenner more than expected).

Fields of papers citing papers by Erica J. Brenner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erica J. Brenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erica J. Brenner. The network helps show where Erica J. Brenner may publish in the future.

Co-authorship network of co-authors of Erica J. Brenner

This figure shows the co-authorship network connecting the top 25 collaborators of Erica J. Brenner. A scholar is included among the top collaborators of Erica J. Brenner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erica J. Brenner. Erica J. Brenner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brenner, Erica J., Xian Zhang, Uma Mahadevan, et al.. (2025). Risk Factors for Contraceptive Failure and Unintended Pregnancy Among Women With Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 31(5). 1460–1465.
2.
Brenner, Erica J.. (2025). The No-Biopsy Approach for Pediatric Celiac Disease: Ready for Prime Time in North America?. The American Journal of Gastroenterology. 120(9). 1985–1986.
3.
Brenner, Erica J., Mary E. Grewe, Amy G. Bryant, et al.. (2024). Perspectives on Contraception, Pregnancy, and Reproductive Health Counseling from Young Women With Inflammatory Bowel Disease. Crohn s & Colitis 360. 7(1). otae078–otae078. 1 indexed citations
4.
Brenner, Erica J., Li Lin, Millie D. Long, et al.. (2023). Computerized-adaptive testing versus short forms for pediatric inflammatory bowel disease patient-reported outcome assessment. Journal of Clinical and Translational Science. 7(1). e109–e109.
5.
Brenner, Erica J., Xian Zhang, Millie D. Long, Marla C. Dubinsky, & Michael D. Kappelman. (2023). High Use of Estrogen-based Contraceptives in Young Women With Inflammatory Bowel Disease in the United States. Clinical Gastroenterology and Hepatology. 22(2). 427–429.e28. 2 indexed citations
6.
Zhang, Xian, Erica J. Brenner, Manasi Agrawal, et al.. (2022). Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry. Inflammatory Bowel Diseases. 28(7). 1126–1129. 5 indexed citations
7.
Kaplan, Gilaad G., Fox E. Underwood, Stephanie Coward, et al.. (2022). The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis. Inflammatory Bowel Diseases. 28(11). 1687–1695. 3 indexed citations
8.
Brenner, Erica J., et al.. (2022). The safe use of inflammatory bowel disease therapies during the COVID-19 pandemic. SHILAP Revista de lepidopterología. 3. 100101–100101. 3 indexed citations
9.
Agrawal, Manasi, Xian Zhang, Erica J. Brenner, et al.. (2021). The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry. Journal of Crohn s and Colitis. 15(11). 1877–1884. 15 indexed citations
10.
Ungaro, Ryan C., Manasi Agrawal, Erica J. Brenner, et al.. (2021). New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International Registry. Inflammatory Bowel Diseases. 28(2). 314–317. 8 indexed citations
11.
Zhang, Xian, Ryan C. Ungaro, Erica J. Brenner, et al.. (2021). Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences. 67(4). 1271–1277. 7 indexed citations
12.
Ricciuto, Amanda, Christopher A Lamb, Eric I. Benchimol, et al.. (2021). Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients. Journal of Crohn s and Colitis. 16(4). 591–600. 18 indexed citations
13.
Ungaro, Ryan C., Erica J. Brenner, Manasi Agrawal, et al.. (2021). Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry. Gastroenterology. 162(1). 316–319.e5. 34 indexed citations
14.
Brenner, Erica J., et al.. (2021). Peripheral eosinophilia and hypoalbuminemia are associated with a higher biopsy diagnostic yield for eosinophilic gastroenteritis. Clinics and Research in Hepatology and Gastroenterology. 45(5). 101746–101746. 11 indexed citations
15.
Ungaro, Ryan C., Erica J. Brenner, Richard B. Gearry, et al.. (2020). Effect of IBD medications on COVID-19 outcomes: results from an international registry. Gut. 70(4). 725–732. 178 indexed citations
16.
Brenner, Erica J., Ryan C. Ungaro, Richard B. Gearry, et al.. (2020). Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. Gastroenterology. 159(2). 481–491.e3. 454 indexed citations breakdown →
17.
Agrawal, Manasi, Erica J. Brenner, Xian Zhang, et al.. (2020). Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry. Journal of Crohn s and Colitis. 15(5). 860–863. 7 indexed citations
18.
Brenner, Erica J., Bénédicte Pigneur, Gili Focht, et al.. (2020). Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases. Clinical Gastroenterology and Hepatology. 19(2). 394–396.e5. 37 indexed citations
19.
Brenner, Erica J. & Millie D. Long. (2019). Diagnosis and treatment of dermatologic diseases in inflammatory bowel disease. Current Opinion in Gastroenterology. 35(4). 330–336. 7 indexed citations
20.
Patel, Chirag G., David M. Kornhauser, N. Vachharajani, et al.. (2011). Saxagliptin, a potent, selective inhibitor of DPP‐4, does not alter the pharmacokinetics of three oral antidiabetic drugs (metformin, glyburide or pioglitazone) in healthy subjects. Diabetes Obesity and Metabolism. 13(7). 604–614. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026